Description
Bladder Cancer
Diagnosis and Clinical Management
Author: LERNER Seth
Language: EnglishSubjects for Bladder Cancer:
Approximative price 148.88 €
In Print (Delivery period: 12 days).
Add to cart the book of LERNER SethDescription
/li>Contents
/li>
Bladder Cancer: Diagnosis and Clinical Management is a 100%
clinically–focused guide to bladder cancer, providing practical, modern
and evidence–based guidance to the latest in diagnosis and management of
the condition. It differs from other books in its complete clinical
focus as opposed to a heavy analysis of pathogenesis or basic science.
As a result, practicing urologists and oncologists in the clinical
setting will find it an essential resource to consult.
In
addition to the latest in diagnostic tools and imaging methods, core
focus is on the management of each form of cancer at its various stages.
Both drug therapies and the range of surgical options are covered,
ensuring that this is the perfect tool for clinicians to consult when
considering which type of management program is appropriate for each
individual patient. A key addition is the final section dedicated to
optimizing health care delivery, featuring chapters on highly topical
issues such as quality of life, patient advocacy and surgical education.
Full color throughout, and packed with excellent images, each chapter contains concise and didactic practical tips and tricks to enrich the reading experience, in addition to management algorithms and the very latest guidelines from the ASCO, AUA, ESMO and EAU concerning clinical management of bladder cancer.
Part I: Diagnosis and Treatment of Non–Muscle Invasive Bladder Cancer
1 Pathology
Hikmat Al–Ahmadie, Donna E. Hansel
2 Risk Stratification of High–grade Ta, Cis and T1 UrothelialCarcinoma
of the Bladder
Tobias Klatte, Fred Witjes, Gary Steinberg,
Shahrokh F.Shariat
3 Utility of Urine Biomarkers
Derya Tilki, Alexandre R. Zlotta
4 Novel Endoscopic Techniques for the Detection of Bladder Cancer
Ayman
Soubra, Joseph C. Liao, Badrinath Konety
5 Transurethral Resection of Bladder Tumors
Jen–Jane Liu, Mark P.
Schoenberg
6 Intravesical Chemotherapy
Levent N. Türkeri, M. Guillaume
Wientjes, Jessie L.S. Au
7 Intravesical Immunotherapy
Nilay M. Gandhi, Laura A. Bertrand,
Donald L. Lamm, Michael A. O Donnell
8 HGT1 Bladder Cancer: Diagnosis and Treatment
J.M. Gaya, J.
Palou, Edward M. Messing
9 What To Do When Bacillus Calmette–Guerin Fails
Massimiliano
Spaliviero, Guido Dalbagni, Matthew Nielsen
Part II: T2–4
10 Selection and Peri–operative Management of Patients Undergoing
Radical Cystectomy and Urinary Reconstruction
Robert S. Svatek,
Alon Z. Weizer
11 Radical Cystectomy: Techniques and Outcomes
Siamak Daneshmand,
Seth P. Lerner
12 Cystectomy in the Female Patient
Ryan Werntz, Georgios Gakis,
Theresa Koppie, Arnulf Stenzl
13 Laparoscopic/Robotic Radical Cystectomy and Urinary Diversion:
Outcomes
Kristina Wittig, Kevin Chan, Mark Kawachi, Timothy
G.Wilson
14 Robotic Assisted Radical Cystectomy and Urinary Diversion: Clinical
Trials
George J.S. Kallingal, Angela B. Smith, Raj S. Pruthi,
Dipen J. Parekh
15 Role of Extended Lymphadenectomy
Eugene K. Cha, George N.
Thalmann, Bernard H.Bochner
16 Management of the Urethra in the Cystectomy Patient
Kamal S.
Pohar, Norm D. Smith
17 The Role of Radical Cystectomy in Patients with Unresectableor
Regionally Metastatic Urothelial Carcinoma of the Bladder
Scott
Delacroix, Jr, Nathan Lawrentschuk, and Ashish M.Kamat
Part III: Primary Bladder Sparing Therapy
18 Radical Transurethral Resection
Eduardo Solsona, Harry W. Herr
19 Partial Cystectomy
Ahmed Haddad, Yair Lotan, Arthur I.
Sagalowsky
20 Integrating Chemotherapy and Radiotherapy for Bladder Cancer
Lior
Z. Braunstein, William U. Shipley, Nicholas D. James, Andrea B. Apolo,
Jason A. Efstathiou
Part IV: Urinary Tract Reconstruction
21 Orthotopic Neobladder
Eila C. Skinner
22 Continent Cutaneous Diversion
Andreas Neisius, Joachim W.
Thüroff
23 Non–continent Urinary Diversion
Michael Rink, Fredrik
Liedberg, Margit Fisch
Part V: Treatment of Regionally Advanced and Metastatic Bladder Cancer
24 Molecular Determinants of Chemotherapy Response
Matthew I.
Milowsky, Peter H. O Donnell, Thomas W. Flaig, Dan Theodorescu
25 Neo–adjuvant Chemotherapy in the Treatment of Muscle–invasive Bladder
Cancer
David I. Quinn, Cora N. Sternberg
26 Adjuvant Chemotherapy for Invasive Bladder Cancer
André P. Fay,
Jeffrey J. Leow, Joaquim Bellmunt
27 Treatment of Metastatic Bladder Cancer
Gopa Iyer, Fabio
Calabró, Dean F. Bajorin
28 Treatment of Poor Risk Patients
Maria De Santis, Matthew D.
Galsky
Part VI: Genomics and the Current Status of Urothelial Cancer
29 Molecular Events in Muscle–invasive Bladder Cancer Development
Jonathan
Rosenberg, William Y. Kim, Jaegil Kim, David J.Kwiatkowski
30 Cancer Stem Cells and Intrinsic Subtypes in Bladder Cancer
Keith
Syson Chan, David J. McConkey
31 Multi–targeted Agents in Treatment of Urothelial Carcinoma
Noah
M. Hahn, Colin P.N. Dinney, Guru Sonpavde
Part VII: Optimizing Health Care Delivery
32 Patient Navigation and Cancer Navigator Programs
Scott M.
Gilbert, Michael Porter
33 Impact of Health Services on Compliance and Outcomes
Heather
Honoré Goltz, Marc A. Kowalkowski, G. John Chen, David M. Latini
34 Quality of Life and Survivorship
Nihal E. Mohamed, Cheryl T. Lee
35 Bladder Cancer: Health Care Delivery and Third Party Payers
Seth
A. Strope, John L. Gore
36 Bladder Cancer Patient Advocacy: Creating Partnerships to Advance
Patient Care, Research, and Clinical Trials
Diane Zipursky Quale,
Rick Bangs
These books may interest you
Urinary Bladder Pathology 147.69 €